ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 24 filers reported holding ARCA BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $286,163 | -9.4% | 142,349 | -8.5% | 0.00% | – |
Q2 2023 | $315,939 | +2.0% | 155,635 | 0.0% | 0.00% | – |
Q1 2023 | $309,713 | +84290.5% | 155,635 | 0.0% | 0.00% | – |
Q4 2022 | $367 | -99.9% | 155,635 | -0.2% | 0.00% | – |
Q3 2022 | $321,000 | +25.4% | 155,870 | +51.5% | 0.00% | – |
Q2 2022 | $256,000 | +15.8% | 102,911 | +6.8% | 0.00% | – |
Q1 2022 | $221,000 | +7.8% | 96,326 | +1.0% | 0.00% | – |
Q4 2021 | $205,000 | -27.3% | 95,358 | 0.0% | 0.00% | – |
Q3 2021 | $282,000 | -7.5% | 95,358 | +8.8% | 0.00% | – |
Q2 2021 | $305,000 | +5.9% | 87,659 | +10.7% | 0.00% | – |
Q1 2021 | $288,000 | +119.8% | 79,151 | +141.7% | 0.00% | – |
Q4 2020 | $131,000 | – | 32,752 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Standard LLC | 1,174,270 | $2,360,283 | 2.13% |
BML Capital Management, LLC | 706,930 | $1,420,929 | 1.30% |
Newtyn Management, LLC | 300,000 | $603,000 | 0.15% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,948 | $94,365 | 0.00% |
OSAIC HOLDINGS, INC. | 55 | $110 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 42,514 | $85,453 | 0.00% |
Parallel Advisors, LLC | 244 | $490 | 0.00% |
BANK OF AMERICA CORP /DE/ | 31 | $62 | 0.00% |
WELLS FARGO & COMPANY/MN | 75 | $151 | 0.00% |
NORTHERN TRUST CORP | 20,982 | $42,174 | 0.00% |